[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 137,755,552
  • Shares Outstanding, K 5,699,444
  • Annual Sales, $ 62,579 M
  • Annual Income, $ 7,771 M
  • EBIT $ 19,384 M
  • EBITDA $ 25,976 M
  • 60-Month Beta 0.35
  • Price/Sales 2.21
  • Price/Cash Flow 5.52
  • Price/Book 1.53

Options Overview Details

View History
  • Implied Volatility 23.39% (-0.11%)
  • Historical Volatility 21.90%
  • IV Percentile 38%
  • IV Rank 32.33%
  • IV High 34.15% on 10/10/25
  • IV Low 18.25% on 08/18/25
  • Expected Move (DTE 5) 0.44 (1.83%)
  • Put/Call Vol Ratio 0.40
  • Today's Volume 62,461
  • Volume Avg (30-Day) 119,767
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 2,485,672
  • Open Int (30-Day) 2,421,526
  • Expected Range 23.73 to 24.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.68
  • Number of Estimates 6
  • High Estimate $0.69
  • Low Estimate $0.66
  • Prior Year $0.78
  • Growth Rate Est. (year over year) -12.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.62 +2.33%
on 07/06/26
26.49 -8.76%
on 06/12/26
-1.43 (-5.59%)
since 06/10/26
3-Month
23.62 +2.33%
on 07/06/26
27.84 -13.20%
on 04/20/26
-2.75 (-10.22%)
since 04/10/26
52-Week
23.11 +4.59%
on 08/01/25
28.75 -15.92%
on 04/02/26
-1.61 (-6.25%)
since 07/10/25

Most Recent Stories

More News
U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

First and only treatment regimen for adults with MIBC, regardless of cisplatin eligibility, representing a platinum-free potential standard of care Broadened...

PFE : 24.17 (-0.33%)
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off

1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off

UFPT : 236.91 (-5.13%)
PFE : 24.17 (-0.33%)
BIIB : 199.15 (+0.12%)
Trump’s Newly Disclosed Moderna Trades Preceded FDA Advisory Panel’s Unanimous Backing of mRNA Flu Vaccine

President Donald Trump’s stock transaction filings reveal multiple purchases of Moderna ($MRNA) during March 2026, followed by a partial sale on May 18. Since those trades, the FDA's Vaccines and Related...

MRNA : 68.27 (-10.83%)
PFE : 24.17 (-0.33%)
GSK : 52.78 (+0.59%)
Haleon Just Struck a Five-Year Deal With Microsoft. Here Is What It Means for Haleon Stock.

Haleon has struck a five-year partnership with Microsoft as it looks to expand its AI transformation using Microsoft's Copilot.

TGT : 135.14 (+2.17%)
MSFT : 385.10 (+0.19%)
$SRCS : 930.18 (+0.85%)
COST : 916.25 (+0.36%)
NVS : 154.05 (-0.37%)
HLN : 9.76 (+0.51%)
GSK : 52.78 (+0.59%)
PFE : 24.17 (-0.33%)
WMT : 113.90 (+1.51%)
2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Turn Down

2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Turn Down

LKQ : 25.38 (-0.04%)
DXCM : 74.96 (+2.66%)
PFE : 24.17 (-0.33%)
2 Large-Cap Stocks to Target This Week and 1 We Find Risky

2 Large-Cap Stocks to Target This Week and 1 We Find Risky

CVNA : 65.83 (-1.92%)
PFE : 24.17 (-0.33%)
MLM : 577.72 (+1.02%)
Pfizer Declares Third-Quarter 2026 Dividend

Board of Directors approves quarterly cash dividend of $0.43 per share

PFE : 24.17 (-0.33%)
FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

First and only CDK4/6 inhibitor approved for HR+ metastatic disease regardless of HER2 status Approval based on data from the collaborative Phase 3 PATINA...

PFE : 24.17 (-0.33%)
Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, August 4, 2026. The purpose...

PFE : 24.17 (-0.33%)
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Pfizer Inc. (NYSE: PFE) today announced topline results from the Phase 3 SigVie-002 study (previously known as Be6A Lung-01) evaluating sigvotatug vedotin, an investigational, potential first-in-class...

PFE : 24.17 (-0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 24.67
2nd Resistance Point 24.54
1st Resistance Point 24.35
Last Price 24.17
1st Support Level 24.04
2nd Support Level 23.91
3rd Support Level 23.72

See More

52-Week High 28.75
Fibonacci 61.8% 26.59
Fibonacci 50% 25.93
Fibonacci 38.2% 25.26
Last Price 24.17
52-Week Low 23.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.